These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8890678)

  • 1. Reduced benzodiazepine sensitivity in patients with panic disorder: comparison with patients with obsessive-compulsive disorder and normal subjects.
    Roy-Byrne P; Wingerson DK; Radant A; Greenblatt DJ; Cowley DS
    Am J Psychiatry; 1996 Nov; 153(11):1444-9. PubMed ID: 8890678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzodiazepine sensitivity in panic disorder: effects of chronic alprazolam treatment.
    Cowley DS; Roy-Byrne PP; Radant A; Ritchie JC; Greenblatt DJ; Nemeroff CB; Hommer DW
    Neuropsychopharmacology; 1995 Apr; 12(2):147-57. PubMed ID: 7779243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzodiazepine sensitivity in normal human subjects.
    Hommer DW; Matsuo V; Wolkowitz O; Chrousos G; Greenblatt DJ; Weingartner H; Paul SM
    Arch Gen Psychiatry; 1986 Jun; 43(6):542-51. PubMed ID: 2871819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced benzodiazepine sensitivity in panic disorder.
    Roy-Byrne PP; Cowley DS; Greenblatt DJ; Shader RI; Hommer D
    Arch Gen Psychiatry; 1990 Jun; 47(6):534-8. PubMed ID: 2161643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of benzodiazepine use in a transdiagnostic sample of panic disorder, social anxiety disorder, and obsessive-compulsive disorder patients.
    Laurito LD; Loureiro CP; Dias RV; Vigne P; de Menezes GB; Freire RC; Stangier U; Fontenelle LF
    Psychiatry Res; 2018 Apr; 262():237-245. PubMed ID: 29475102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diazepam versus alprazolam for the treatment of panic disorder.
    Noyes R; Burrows GD; Reich JH; Judd FK; Garvey MJ; Norman TR; Cook BL; Marriott P
    J Clin Psychiatry; 1996 Aug; 57(8):349-55. PubMed ID: 8752017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory response of patients with panic and obsessive-compulsive disorders to 35% CO2 challenges.
    Perna G; Bertani A; Arancio C; Ronchi P; Bellodi L
    Am J Psychiatry; 1995 Jan; 152(1):85-9. PubMed ID: 7802126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of acute and chronic benzodiazepines on plasma GABA in anxious patients and controls.
    Roy-Byrne PP; Cowley DS; Hommer D; Greenblatt DJ; Kramer GL; Petty F
    Psychopharmacology (Berl); 1992; 109(1-2):153-6. PubMed ID: 1365649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced benzodiazepine sensitivity in patients with premenstrual syndrome: a pilot study.
    Sundström I; Ashbrook D; Bäckström T
    Psychoneuroendocrinology; 1997 Jan; 22(1):25-38. PubMed ID: 9141149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactate-induced anxiety after imipramine and diazepam treatment.
    Pohl R; Balon R; Berchou R; Lycaki H
    Anxiety; 1994; 1(2):54-63. PubMed ID: 9160549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eye movement effects of diazepam in sons of alcoholic fathers and male control subjects.
    Cowley DS; Roy-Byrne PP; Radant A; Hommer DW; Greenblatt DJ; Vitaliano PP; Godon C
    Alcohol Clin Exp Res; 1994 Apr; 18(2):324-32. PubMed ID: 8048734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obsessions with aggressive content emerging during the course of panic disorder: a different subtype of obsessive-compulsive disorder?
    Fontenelle LF; Mendlowicz MV; Kalaf J; Domingues AM; Versiani M
    Int Clin Psychopharmacol; 2005 Nov; 20(6):343-6. PubMed ID: 16192846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapy of anxious disorders.
    Bourin M; Lambert O
    Hum Psychopharmacol; 2002 Dec; 17(8):383-400. PubMed ID: 12457374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obsessive-compulsive and panic symptoms in patients with first-admission psychosis.
    Craig T; Hwang MY; Bromet EJ
    Am J Psychiatry; 2002 Apr; 159(4):592-8. PubMed ID: 11925297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alprazolam as treatment for a case of obsessive-compulsive disorder.
    Tesar GE; Jenike MA
    Am J Psychiatry; 1984 May; 141(5):689-90. PubMed ID: 6143507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of diphenhydramine on human eye movements.
    Hopfenbeck JR; Cowley DS; Radant A; Greenblatt DJ; Roy-Byrne PP
    Psychopharmacology (Berl); 1995 Apr; 118(3):280-6. PubMed ID: 7617820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenomenological and pharmacological study of provoked obsessive/anxiety symptoms in obsessive-compulsive disorder: a preliminary study.
    Kim SW; Dysken MW; Kushner MG; Kuskowski MA; Hoover KM; Klein KW; Faris PL; Hartman BK
    Biol Psychiatry; 1997 Dec; 42(11):969-75. PubMed ID: 9386847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in latency to first pharmacological treatment (duration of untreated illness) in anxiety disorders: a study on patients with panic disorder, generalized anxiety disorder and obsessive-compulsive disorder.
    Dell'Osso B; Camuri G; Benatti B; Buoli M; Altamura AC
    Early Interv Psychiatry; 2013 Nov; 7(4):374-80. PubMed ID: 23347385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personality and benzodiazepine sensitivity in anxious patients and control subjects.
    Cowley DS; Roy-Byrne PP; Greenblatt DJ; Hommer DW
    Psychiatry Res; 1993 May; 47(2):151-62. PubMed ID: 8341768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cortico-subcortical electrophysiological study during the effects of benzodiazepines in patients with panic disorders].
    Guerrero Figueroa R; Heath RG; Escobar-Juyo A; Caballero-García G; Blanco-Castillo I
    Rev Neurol; 2001 Feb 16-28; 32(4):321-7. PubMed ID: 11333385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.